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N,N-Dimethylformamide (DMF) was
tested as part ofa structure-activity study,
using the RACB protocol and Swiss CD-1
mice, to generate some public-domain
reproduction data on this high volume
chemical with known developmental toxic-
ity. Data on food and water consumption,
body weights, and clinical signs during a 2-
week dose-range-finding study (Task 1)
were used to set exposure concentrations for
the Task 2 continuous cohabitation study at
1000, 4000, and 7000 ppm in drinking
water. Based on mean body weight and
average water consumption data, these con-
centrations produced estimated daily con-
sumptions ofapproximately 200, 700, and
1200 mg/kg/day, respectively.
In the Fo animals, there was a progres-
sive decrease in fertility that was faster in
the high dose and middle dose animals
than was observed in the controls (90 -+
55%, 100 -> 70%, and 100 -e 92%,
respectively). The average number oflitters
per pair was reduced in the middle and
high dose groups by 8 and 22%, compared
to controls, while the average number of
pups per litter was reduced by 36 and
55%, respectively. Concomitantly, the
average live pup weight adjusted for litter
size was reduced in these two dose groups
by 18 and 21%.
Pups born to DMF-treated pairs had
deformations, which included domed heads
and hematomas on the head and face. The
proportions oflitters with greater than or
equal to 1 abnormal pup (from control to
high dose) were 8, 11, 90, and 80%, respec-
tively. The slight decrease at the top dose
group is attributed to cannibalism of the
most-affected pups.
The cumulative days to deliver each lit-
ter was increased only at the high dose and
only statistically for litter 3, though all
other means at this dose level were greater
than control. While postpartum sire weights
were never reduced by DMF, dam weights
after delivery ofthe 5th litter were reduced
in all treated groups by 7, 8, and 9%, from
low to high dose. Female feed consumption
was increased by 10 to 16% in the middle
and high-dose groups.
Pups from the last litter were reared by
the dam until weaning, and then con-
sumed the same levels ofDMF provided to
their parents. There were dose-related
reductions in feed and water consumption
by the dams during nursing, from 13 to
approximately 30%. There was increased
postnatal mortality in pups in the middle
and high dose groups but no reductions in
pup weight gain pre-weaning.
After weaning this last litter, a crossover
mating trial was conducted using the con-
trol and high dose mice. No statistical dif-
ferences from control were found, although
the litters delivered to 7000 ppm DMF-
treated females were 32% smaller than
those delivered to control pairs. Skeletal
and soft-tissue examination of pups born
during Task 3 found that pups born to
DMF-treated dams showed the same spec-
trum of malformations as seen in Task 2,
and these litters also had more skeletally
malformed fetuses per litter than controls
(95 vs 40%).
After the Task 3 litters were delivered,
evaluated, and killed, the Fo mice were killed
and necropsied. There was no significant dif-
ference between male body weights, though
the high dose group weighed approximately
8% less than controls. Relative liver weights
in males were increased by 24, 52, and 52%
in the low, middle, and high dose groups,
respectively. These same groups also had
increased caudal epididymis weights (31,
23, and 26%, respectively), while only the
high dose group showed an increase in rela-
tive kidney weights (15%). There were no
changes in sperm end points, although tes-
ticular spermatid head count was reduced
in the low and high dose groups by 25 and
19%, respectively. For Fo females, high
dose body weights were reduced by 11%,
while in the low, middle, and high dose
groups, relative liver weight was increased
by 31, 46, and 35%, respectively, while
relative kidney weight was increased by 7,
7, and 13%. There was no difference
between the control and high dose females
in estrous parameters. There were no sig-
nificant dose-related microscopic findings
in the Fo mice.
All dose groups and controls were eval-
uated in theFI mating trial where only half
of the cohabited pairs in the middle and
high dose groups had a litter, versus 90%
of controls. Dam weights were reduced by
14 and 18% in the middle and high dose
groups, respectively. Also in these two
groups, litter size was reduced by 57 and
64%, respectively, while adjusted pup
weight was reduced in the low to high
groups, by 6, 25, and 24%, respectively. In
the control, low, middle, and high dose
groups, the proportion ofpups that showed
similar malformations to those seen earlier
were 0, 28, 60, and 75%.
After the F2 pups were delivered, evalu-
ated, and killed, the Fl adults were killed
and necropsied. In males, there was a 10
and 6% reductions in body weight seen in
the middle and high dose groups, respec-
tively. From the low to high dose groups,
liver weight was increased by 37, 54, and
57%, and prostate weight was reduced by
13, 15, and 24%, respectively. There was a
monotonic decrease in epididymal sperm
concentration which reached statistical sig-
nificance at the high dose (20% reduced);
no other sperm measure was affected.
In females, body weight in the middle
and high dose groups was reduced by 12
and 12%, while relative kidney weights
were increased by 10% in both groups.
Relative liver weights were increased in
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dams from the low to high dose groups by
23, 37, and 34%, respectively. Estrous cycle
length was significantly increased in high
dose treated females, and fewer of these
females had cycles. In both sexes, micro-
scopic findings were minimal and not
strongly related to dose.
These data show that N,N-dimethyl-
formamide at greater than or equal to
4000 ppm reduced fertility, and at greater
than or equal to 1000 ppm increased
malformations in offspring. These effects
occurred concomitant with increases in
liver weights, but at doses lower than
those required to reduce body weight.
Although the female appears to be the
most affected sex, data from the crossover
mating trial also are consistent with these
effects being couple-dependent, as there
was no clear fertility difference between
the sexes.
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Summary: NTP Reproductive Assessment by Continuous Breeding Study.
NTIS#: PB92123842
Chemical: N,N-Dimethylformamide
CAS#: 68-12-2
Mode of exposure: Drinking water
Species/strain: Swiss CD-1 mice
F generation Dose concentration - 1000 ppm 4000 ppm 7000 ppm
Bodyweight .
Kidneyweight' _
Liverweight' t,t tT t T
Mortality
Feed consumption . ,1 --- - - t
Waterconsumption _ . . .
Clinical signs .- t T ,T
xlitters/pair
#live pups/litter pupwi/litter -, 4 _ s
Cumulative daysto litter __
Absolutetestis, epididymis weigh? e --, t ,
Sexaccessory glandweight'(prostate, seminal vesicle) - . _ -
Epidid. sperm parameters (#, motility, morphology) ,-, , .- . .-
Estrous cycle length . .
[Determinationofaffected sex(crossover) Male Female - Both
Doselevel ] _ I _ | -
F, generation Dose concentration-. lOmppm 4000 ppm 7000 ppm
Pupgrowth toweaning ,
Mortality _ _ t,t
Adultbodyweight 4,4
Kidneyweight' .__ .
Liverweight' t,t 'Vt tjt
Feed consumption
Waterconsumption -- - _ _ _
Clinical signs _, , t t,t
Fertility index
#livepups/litter; pupwt./litter 4 4 4,4
Absolutetestis, epididymisweight'
Sexaccessoryglandweight'(prostate,seminalvesicle) 4 , , -
Epidid._spermparameters(Imotility, morphology) ___ _ ___ _ _-_
Estrous cycle length . .
Affected sex? Unclear
Studyconfounders: None
NOAELreproductivetoxicity: <1000ppm
NOAELgeneraltoxicity: <1000ppm
F1 more sensitivethanFo? No
Postnatal toxicity: Yes
Legend: -, no change; *, no observation; I or4-, statistically significant change (p<0.05); ,-, no change in males orfemales. 'Adjusted for bodyweight.
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